China Clears Market Of Tainted Drug Capsules; Penalizes 76 Officials
This article was originally published in PharmAsia News
Executive Summary
China’s State FDA has completed its operations to clear marketed contaminated drug capsules, and doles out punishments for 76 officials from six provinces.
China’s State FDA has completed its operations to clear marketed chromium-contaminated drug capsules. The operations led to punishments for seven officials at the prefecture level, 24 officials from the county-level, and 45 officials from village-level or lower municipalities in Zhejiang, Henan, Sichuan, Hebei, and Jiangsu provinces and Chongqing city. SFDA will continue handling reported illegal capsule cases in accordance with the law and requested that its regional branches accelerate their regular inspections, particularly of those involved in the earlier scandal. The Chinese pharma authorities have pulled all substandard capsule drugs launched before May off the market and have reportedly found no contaminated capsule drugs for those launched thereafter. (Click Here For More - Chinese Language
)
“China Clears Capsule Drugs With Over-Limit Chrome Off Market, Handles 76 Officials From Six Provinces” - news.ifeng.com (8/3/2012)